For research and educational purposes only. Not medical advice.
BMS-564929 Reference
Educational, not medical advice reference for BMS-564929: SARM; regulatory status, evidence posture, source review, and schedule notes. Also known as Non-ste…
Reference summary
Phase 1 healthy-men trial existed; no later development. Tissue-selectivity profile was studied in early development.
- Categories
- SARM
- Aliases
- Non-steroidal SARM, Bristol-Myers Squibb investigational
- Evidence posture
- preclinical — FDA enforcement attention. Sold only as a research chemical, not for human consumption per legal seller terms. WADA-prohibited under category S1.2 at all times. Did not advance past early development by the original sponsor; community use extrapolates from minimal published data.
- Regulatory status
- No FDA-approved BMS-564929 drug label. WADA prohibits SARMs under category S1.2 at all times. FDA enforcement against SARMs sellers applies. BMS-564929 was an early Bristol-Myers Squibb SARM investigational candidate that did not advance.
- Content review status
- research reference